Effects of proteasome inhibitor MG-132 on heart function and cardiac troponin Ⅰ in rats with chronic heart failure caused by myocardial infarction

Dai Cuilian,Jiang Qianfeng,Zhang Yun

DOI: https://doi.org/10.16016/j.1000-5404.2011.01.012

2011-01-01

Abstract:Objective To investigate the effects of proteasome inhibitor MG-132 on the ubiquitin-proteasome system and on heart function and cardiac troponin Ⅰ(cTnI) in rats with chronic heart failure(CHF) caused by myocardial infarction(MI).Methods Coronary artery ligation was used to build animal models of CHF.Forty-five adult Sprague-Dawley rats were randomly divided into 3 groups: MG-132 group,MI group,and Sham group.In the MG-132 group,the ligation of left anterior descending coronary arteries and the intraperitoneal injection of MG-132 [0.1 mg/(kg·d),dissolved in 0.9% saline 2 ml] were performed.In the MI group,the ligation of left anterior descending coronary arteries and the intraperitoneal injection of saline(2 ml/d) were performed.In the Sham group,rats also underwent the intraperitoneal injection of saline(2 ml/d),but threads were only passed through the left anterior descending coronary arteries without completing the ligation.After intraperitoneal injection in the three groups continually for 7 weeks,hemodynamics and serum B-type natriuretic peptide level were measured,sarcomere morphology change was measured by electronic microscopy,and the mRNA level and protein expression of myocardial cTnI were investigated by real-time PCR and Western blotting.Results The MG-132 group,compared with the MI group,demonstrated lower mortality(0 vs 20%),higher systolic left ventricular pressure(LVPS)(85.69±14.65 mmHg vs 71.22±7.89 mmHg,P<0.05) and +dp/dtmax(2 327.57±597.96 mmHg/s vs 1 047.20±168.65 mmHg/s,P<0.001),and lower left ventricular end-diastolic pressure(LVEDP)(16.85±2.05 mmHg vs 23.40±6.08 mmHg,P<0.001) and NT-proBNP level(1 474.15±702.61 pg/ml vs 3 920.56±1 919.04 pg/ml,P<0.001).MG-132 improved the sarcomere morphology and upregulated the mRNA and protein expressions of myocardial cTnI(2.4±1.1 vs 0.6±0.2,P<0.01;0.83±0.07 vs 0.63±0.10,P<0.05).Conclusion Our results demonstrate that inhibiting ubiquitin-proteasome system can improve the prognosis of CHF caused by myocardial infraction by decreasing the cTnI degradation.In addition,MG-132 can improve the sarcomere morphology,and this is associated with the upregulation of mRNA and protein expressions of myocardial cTnI.